Opaganib is a chemical compound that acts as an inhibitor of sphingosine kinase 2, dihydroceramide desaturase, and glucosylceramide synthase. It is under investigation as a potential pharmaceutical intermediate for research in oncology and antiviral applications, including preclinical studies against SARS-CoV-2.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 915385-81-8
Neratinib maleate
pharmaceutical raw material
(3R,4R)-benidipine hydrochloride
pharmaceutical raw material
(17S)-methylnaltrexone bromide
pharmaceutical raw material
2-Tolperisone Hydrochloride
pharmaceutical raw material
3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide
CAOTVXGYTWCKQE-UHFFFAOYSA-N
C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl